[Federal Register Volume 65, Number 14 (Friday, January 21, 2000)]
[Notices]
[Page 3469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-1417]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning Individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel HIV Vaccine Clinical Trial Units.
    Date: February 10-11, 2000.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. James Suites, St. James Room, 950 24th Street, NW., 
Washington, DC 20037.
    Contact Person: Hagit S. David, Scientific Review Administrator, 
Scientific Review Program, Division of Extramural Activities, NIAID, 
NIH, Room 2217, 6700-B Brockledge Drive, MSC, 7610, Bethesda, MD 
20892-7610, 301-496-2550.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 12, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-1417 Filed 1-20-00; 8:45 am]
BILLING CODE 4140-01-M